SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
6 references·1 citing·28 second hop
“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed! (2014)“Go no Go” in plasma fractionation in the…Should Blood Be an Essential Medicine? (2013)Should Blood Be an Essential …External Financial Aid to Blood Transfusion Services in Sub-Saharan Africa: A Need for Reflection (2012)External Financial Aid to Blo…Emerging pathogens and their implications for the blood supply and transfusion transmitted infections (2012)Emerging pathogens and their …Economical impact of plasma fractionation project in Iran on affordability of plasma‐derived medicines (2009)Economical impact of plasma f…Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience (2008)Plasma fractionation, a usefu…Reducing the risk of infection from plasma products: specific preventative strategies (2000)Reducing the risk of infectio…Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries (2023)Challenges associated with ac…The Norwegian plasma fractionation project––a 12 year clinical and economic success story (2003)Plasma for fractionation: safety and quality issues (2004)Introduction to Iranian Blood Transfusion Organization and Blood Safety in Iran (2009)Cost effectiveness of Iran national plasma contract fractionation program (2012)The History and Development of the Plasma Protein Fractionation Industry (2012)A qualitative, patient-centered perspective toward plasma products supply chain network design with risk controlling (2020)Emerging infectious disease agents and their potential threat to transfusion safety (2009)Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium (2016)Reevaluating Canada’s policy for blood donations from men who have sex with men (MSM) (2016)The American Rare Donor Program: 25 years supporting rare blood needs (2024)The Risk of Transfusion-Transmitted Viral Infections (1996)Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Emerging viral threats to the Australian blood supply (2008)Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria. (2009)Helping doctors hasten COVID-19 treatment: Towards a rescue framework for the transfusion of best convalescent plasma to the most critical patients based on biological requirements via ml and novel MCDM methods (2020)Legal, Financial, and Public Health Consequences of HIV Contamination of Blood and Blood Products in the 1980s and 1990s (2002)Blood safety concerns in the Eastern Mediterranean region. (2011)Maternal mortality in sub‐Saharan Africa: the contribution of ineffective blood transfusion services (2008)Payment, compensation and replacement - the ethics and motivation of blood and plasma donation (2010)Moving on from voluntary non‐remunerated donors: who is the best blood donor? (2011)Can family or replacement blood donors become regular volunteer donors? (2013)Family donors are critical and legitimate in developing countries (2015)Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions (2021)Viral Safety of Human Plasma–Derived Medicinal Products: Impact of Regulation Requirements (2013)Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of Blood Transfusion Workshop (2022)The costs of producing a unit of blood in Z imbabwe (2015)Shortage of plasma-derived products: a looming crisis? (2022)Future Blood Debt: Projecting Blood Supply and Demand of Korea Based on Subnational Population Projections (2021–2050) (2024)
this work references cited by second hop

References

  • 2000Reducing the risk of infection from plasma products: specific preventative strategies195 cited
  • 2012External Financial Aid to Blood Transfusion Services in Sub-Saharan Africa: A Need for Reflection80 cited
  • 2012Emerging pathogens and their implications for the blood supply and transfusion transmitted infections68 cited
  • 2013Should Blood Be an Essential Medicine?38 cited
  • 2008Plasma fractionation, a useful means to improve national transfusion system and blood safety: Iran experience36 cited
  • 2009Economical impact of plasma fractionation project in Iran on affordability of plasma‐derived medicines21 cited

Cited by

  • 2023Challenges associated with access to plasma‐derived medicinal products in low middle‐income and low‐income countries8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work